Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sherry Aulin currently holds 6,000 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sherry Aulin has been a net seller of XENE stock. They have purchased $0 and sold $607.6K worth of shares.
Sherry Aulin's most recent insider trade was on Dec 18, 2024, when they sold 9,334 shares at $0.00 per share.
Sherry Aulin serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 10 insider transactions totaling $607.6K over their tenure at the company.
Sherry Aulin holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sherry Aulin has shown a selling trading pattern, with $0 in total purchases and $607.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sherry Aulin was on Sep 2, 2022, when they sold $607.6K worth of XENE shares. This transaction involved 15,355 shares at $39.57 per share.
Sherry Aulin currently owns 6,000 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sherry Aulin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sherry Aulin has 10 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Sherry Aulin and 40,000+ other insiders.